title: Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding.
authors.affiliation: Department of Haematology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Aberdeen, UK. henrywatson@nhs.net
authors.forename: Henry G
authors.initials: HG
authors.lastname: Watson
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin